Windtree’s Innovative Drugs Show Promising Reductions in Ventricular Arrhythmias
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a Pennsylvania-based biotechnology company, has announced new preclinical data on two of its drug candidates, istaroxime and CVie-216. The drugs have shown …
Windtree’s Innovative Drugs Show Promising Reductions in Ventricular Arrhythmias Read More